MHRA extends access to Santhera's DMD drug via the EAMS

23rd June 2020 Uncategorised 0

The scientific opinion has been extended for one year while the drug is under regulatory review

More: MHRA extends access to Santhera's DMD drug via the EAMS
Source: News